ECO Animal Health Group plc (LON:EAH) has announced the publication of the following documents on the Company’s website: www.ecoanimalhealthgroupplc.com/investor-relations.aspx.
· Annual Report and Accounts for the year ended 31 March 2022
· Notice of Annual General Meeting to be held at The Grange, 100 High Street, London, N14 6BN on 26 September 2022 at 11.30am (“AGM”) and Form of Proxy
The Documents will be posted today to those shareholders that have elected to receive them by post.
ECO Animal Health Group plc (LON:EAH) has announced its results for the six months ended 30 September 2023. HIGHLIGHTS Financial · Group Revenue increased 9% to £38.0 million (H1 2022: £34.9 million) o Revenues on a constant currency basis increased 15%
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be hosting two Capital Markets events focused on progress and developments in
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, will be hosting a Capital Markets Day presentation for retail investors focusing on progress and developments
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has received a new US and Canadian label claim indication for Aivlosin® Water Soluble Granules
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has achieved an A-rating for its ESG activities from Integrum ESG, who provide independent
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that the Company is today posting to shareholders notice of the Company’s Annual General Meeting
ECO Animal Health’s David Hallas discusses a strong set of results, growth drivers, product markets and optimism for the year ahead in this exclusive interview with DirectorsTalk.
ECO Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk to discuss results for the year ended 31st March 2023. David talks us through the highlights, explains what was behind the growth in revenues, profitability and the improved
ECO Animal Health Group plc (LON:EAH) have today provided final results for the year ended 31 March 2023. HIGHLIGHTS Financial · Revenue and adjusted EBITDA ahead of market expectations · Group sales increased by 4% to £85.3m, driven primarily by growth
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, will issue its results for the year ended 31 March 2023 on Monday 10 July 2023. Investor
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has provided an update to its expected results for the year ended 31 March 2023. The
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be participating at the Animal Health, Nutrition and Technology Innovation summit and
Eco Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk Interviews to discuss interim results for the six months ended 20th September. David talks us through the highlights, improved Chinese pork prices, excitement over new product developments, what
ECO Animal Health Group plc (LON:EAH) has announced its results for the six months ended 30 September 2022. HIGHLIGHTS Financials · Group Sales at £34.9 million (H1 2021: £38.5 million) – China and Japan sales declined to £8.5 million (H1
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that David Hallas, CEO, and Christopher Wilks, CFO, will be conducting a live presentation
Following a competitive tender process overseen by the Group’s Audit & Risk Committee, ECO Animal Health Group (LON:EAH) has announced the resignation of BDO LLP as auditor and the appointment, with immediate effect, of Haysmacintyre LLP as auditor for the
ECO Animal Health Group plc (LON:EAH) has announced its results for the year ended 31 March 2022. HIGHLIGHTS Financials · Group sales down 22% at £82.2m (2021: £105.6m) – China and Japan sales declined significantly to £28.4m (2021: £58.9m) – ROW
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has provided an update to its expected results for the year ended 31 March 2022. The audit
© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.